CAS: 139262-76-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | H2L5186303 REF: IN-DA00A0N1CAS: 139262-76-3 | 97% | To inquire | Thu 27 Mar 25 |
 | H2L5186303 REF: TM-T22835CAS: 139262-76-3 | 97.23% | 35.00 €~938.00 € | Thu 15 May 25 |
 | H2L5186303 REF: 3D-PFA26276CAS: 139262-76-3 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00A0N1
| 25mg | 171.00 € | ||
| 50mg | 206.00 € | ||
| 100mg | 464.00 € |
Estimated delivery in United States, on Thursday 27 Mar 2025
H2L5186303
CAS:139262-76-3
H2L5186303 is an LPA2 antagonist and can be used in studies about asthma treatment.
Formula:
C26H20N2O8
Purity:
97.23%
Color and Shape:
Solid
Molecular weight:
488.45
Ref: TM-T22835
| 1mg | 35.00 € | ||
| 5mg | 64.00 € | ||
| 10mg | 104.00 € | ||
| 25mg | 226.00 € | ||
| 50mg | 335.00 € | ||
| 100mg | 470.00 € | ||
| 500mg | 938.00 € | ||
| 1mL*10mM (DMSO) | 75.00 € |
Estimated delivery in United States, on Thursday 15 May 2025
H2L5186303
CAS:139262-76-3
H2L5186303 is a synthetic endocannabinoid that has been shown to have anticancer effects. H2L5186303 binds …
Formula:
C26H20N2O8
Purity:
Min. 95%
Molecular weight:
488.45 g/mol
Ref: 3D-PFA26276
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
